^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
abiraterone (AST-2970)
i
Other names: AST-2970, DST-2970, KABE
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Austhera Biosci
Drug class:
CYP17A1 inhibitor
Related drugs:
2ms
PK and Dose Escalation and Expansion Study of DST-2970 (clinicaltrials.gov)
P1, N=26, Terminated, DisperSol Technologies, LLC | N=54 --> 26 | Active, not recruiting --> Terminated; Dose escalation portion of the study completed, one expansion cohort was eliminated due to change in standard of care, and the second cohort was not enrolled based on future development considerations.
Enrollment change • Trial termination
|
prednisone • abiraterone (AST-2970)
Share via
